Results 141 to 150 of about 1,686 (250)

Neuromorphic Denoising with Fully Analog Memristive In‐Memory Computing

open access: yesAdvanced Intelligent Systems, Volume 8, Issue 8, August 2026.
This article borrows the concepts of episodic memory in human brains to experimentally implement a memristor‐based neuromorphic denoising process. A homogeneous memristor processing unit is experimentally demonstrated for both temporal storage and neural network computation, imitating the synapses in the human brain.
Daijing Shi   +5 more
wiley   +1 more source

Efficacy and Evidence Certainty of High‐Frequency rTMS for Cognitive Impairment Across Neuropsychiatric Disorders: An Umbrella Review

open access: yesBrain and Behavior, Volume 16, Issue 8, August 2026.
This umbrella review of 29 meta‐analyses found that HF‐rTMS significantly improves cognition in Alzheimer's disease and vascular cognitive impairment. However, GRADE shows that most evidence is of low‐to‐very‐low certainty, and AMSTAR‐2 rates over 60% of reviews as critically low quality. Well‐designed trials are urgently needed.
Lin‐ling Wu   +3 more
wiley   +1 more source

The Neuroprotective Potentials of Dual GIP/GLP1‐RA (Tirzepatide): From Preclinical Experiments to Clinical Trials: A Scoping Review

open access: yesBrain and Behavior, Volume 16, Issue 8, August 2026.
The graphical abstract summarizes the current evidence on the potential neuroprotective effects of tirzepatide (TZP), a dual GIP/GLP‐1 receptor agonist, across mechanistic, preclinical, and clinical domains. Mechanistically, TZP is proposed to exert direct neural effects, preserve mitochondrial function, reduce apoptosis, oxidative stress, and ...
Yousef Hawas   +6 more
wiley   +1 more source

The Serotonin 2B (5‐HT2B) Receptor: A Narrative Review of Preclinical and Clinical Evidence on the Safety Considerations and Therapeutic Potential for the Treatment of Depression

open access: yesClinical Pharmacology &Therapeutics, Volume 120, Issue 2, Page 345-356, August 2026.
Major depressive disorder (MDD) and treatment‐resistant depression (TRD) remain leading causes of disability, providing the impetus for receptor‐level treatment strategies beyond monoamine reuptake. The serotonin 5‐HT2B receptor (5‐HT2BR) is uniquely positioned at the interface of central‐antidepressant mechanisms and peripheral cardiac risks.
Gia Han Le   +8 more
wiley   +1 more source

Interferon‐induced transmembrane (IFITM) proteins at the tumour–immune interface: A four‐axis framework for their context‐dependent roles

open access: yesClinical and Translational Medicine, Volume 16, Issue 8, August 2026.
Interferon‐induced transmembrane (IFITM) function in cancer is set by four contextual coordinates, not by family membership. Acute interferon input drives major histocompatibility complex class I (MHC‐I)‐linked immunogenicity; chronic input drives programmed death‐ligand 1 (PD‐L1)‐coupled resistance.
Zhe Liu   +4 more
wiley   +1 more source

A 2-Gbps low-SWaP quantum random number generator with photonic integrated circuits for satellite applications. [PDF]

open access: yesnpj Quantum Inf
Crampton OM   +12 more
europepmc   +1 more source

Home - About - Disclaimer - Privacy